GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Gross Margin %
中文

Medartis Holding AG (XSWX:MED) Gross Margin % : 80.76% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Medartis Holding AG's Gross Profit for the six months ended in Dec. 2023 was CHF87.8 Mil. Medartis Holding AG's Revenue for the six months ended in Dec. 2023 was CHF108.8 Mil. Therefore, Medartis Holding AG's Gross Margin % for the quarter that ended in Dec. 2023 was 80.76%.

Warning Sign:

Medartis Holding AG gross margin has been in long-term decline. The average rate of decline per year is -1.1%.


The historical rank and industry rank for Medartis Holding AG's Gross Margin % or its related term are showing as below:

XSWX:MED' s Gross Margin % Range Over the Past 10 Years
Min: 79.04   Med: 83.26   Max: 85.5
Current: 79.04


During the past 10 years, the highest Gross Margin % of Medartis Holding AG was 85.50%. The lowest was 79.04%. And the median was 83.26%.

XSWX:MED's Gross Margin % is ranked better than
88.94% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs XSWX:MED: 79.04

Medartis Holding AG had a gross margin of 80.76% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Medartis Holding AG was -1.10% per year.


Medartis Holding AG Gross Margin % Historical Data

The historical data trend for Medartis Holding AG's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG Gross Margin % Chart

Medartis Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.50 83.43 83.88 81.77 79.04

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.80 83.66 79.99 77.23 80.76

Competitive Comparison of Medartis Holding AG's Gross Margin %

For the Medical Devices subindustry, Medartis Holding AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's Gross Margin % falls into.



Medartis Holding AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Medartis Holding AG's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=167.6 / 212.006
=(Revenue - Cost of Goods Sold) / Revenue
=(212.006 - 44.434) / 212.006
=79.04 %

Medartis Holding AG's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=87.8 / 108.755
=(Revenue - Cost of Goods Sold) / Revenue
=(108.755 - 20.92) / 108.755
=80.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Medartis Holding AG  (XSWX:MED) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medartis Holding AG had a gross margin of 80.76% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Medartis Holding AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Medartis Holding AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medartis Holding AG (XSWX:MED) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for Cranium, Midface, and mandible. Geographically, it derives majority of the revenue from EMEA and also has a presence in APAC; LATAM and North America.

Medartis Holding AG (XSWX:MED) Headlines